Marshall Wace »

C4 Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.3M 1.1M 5.65
2023-03-31 $356k 113k 3.14
2022-06-30 $1.9M 252k 7.55

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Alphabet Inc-a Equity Option Put Option (GOOGL)
Meta Platforms-a Common Stock (META)
Alphabet Inc-c Common Stock (GOOG)
Walmart Common Stock (WMT)
Abbvie Equity Option Put Option (ABBV)
Las Vegas Sands Common Stock (LVS)
Dr Horton Common Stock (DHI)
Ishares-leh 20 Equity Option Call Option (TLT)
Eli Lilly & Co Right Call Option
General Electric Common Stock (GE)

View all positions for Marshall Wace

Top funds holding C4 Therapeutics

RA Capital Management
Daniel D. Thurber
Commodore Capital
Lynx1 Capital Management
T. Rowe Price Associates
Arrowpoint Asset Management
Vanguard Group
Point72 Asset Management
Soleus Capital Management
Balyasny Asset Management
Bank of America Corporation
Marshall Wace
Millennium Management
Citadel Advisors
Cubist Systematic Strategies

View all funds holding C4 Therapeutics